Immediate Impact
6 standout
Citing Papers
Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
2025 Standout
evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s disease
2025 Standout
Works of Elizabeth Shaffer being referenced
Recruitment into the Alzheimer Prevention Trials (APT) Webstudy for a Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD)
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Elizabeth Shaffer | 10 | 4 | 10 | 17 | 10 | 5 | 38 | |
| Alibek Mereke | 14 | 1 | 6 | 14 | 9 | 6 | 51 | |
| H. Ueshima | 13 | 8 | 7 | 16 | 23 | 7 | 179 | |
| the MEGMI study group | 13 | 6 | 9 | 21 | 10 | 7 | 189 | |
| Taylor Clanton | 8 | 1 | 16 | 26 | 9 | 3 | 39 | |
| Cathy McCann | 27 | 3 | 11 | 8 | 7 | 6 | 190 | |
| Tony Lloyd | 11 | 5 | 7 | 10 | 6 | 6 | 43 | |
| Cerise Elliott | 20 | 4 | 2 | 25 | 10 | 3 | 36 | |
| Marcelo Adrián Maito | 4 | 1 | 3 | 12 | 8 | 5 | 54 | |
| Joanna Bowen | 11 | 1 | 23 | 29 | 7 | 7 | 51 | |
| Samuel Mensah | 9 | 4 | 8 | 4 | 5 | 3 | 40 |
All Works
Loading papers...